Associated findings for postcontrast T1, FLAIR, and combined evaluation in patients with SNHL (P < .05)
| Normal MR Imaging Findings Mean (SD) | Abnormal MR Imaging Findings Mean (SD) | P Value | |
|---|---|---|---|
| Inner ear enhancement on T1+C | |||
| Age at presentation (days) | 95.2 (116.6) | 93.4 (93.5) | .9 |
| Time from presentation to MR imaging (days) | 14.1 (11.4) | 10.1 (6.4) | .3 |
| CSF WBC count | 11692.3 (32,494.4) | 2674.8 (5440.94) | .3 |
| CSF glucose | 29 (14.3) | 18.1 (11) | .04 |
| CSF protein | 309.8 (236.9) | 505.5 (216.1) | .04 |
| FLAIR hyperintensity | |||
| Age at presentation (days) | 74.1 (105.1) | 98.2 (95.5) | .5 |
| Time from presentation to MR imaging (days) | 12.9 (10.7) | 10 (6.6) | .4 |
| CSF WBC count | 8613.9 (27,966.7) | 2843.62 (5624.81) | .5 |
| CSF glucose | 35.5 (22.4) | 17.9 (11.4) | .02 |
| CSF protein | 301.5 (224.1) | 498.54 (223.3) | .03 |
| Combined evaluation | |||
| Age at presentation (days) | 95.2 (116.6) | 93.4 (93.5) | .9 |
| Time from presentation to MR imaging (days) | 14.1 (11.4) | 10.1 (6.4) | .3 |
| CSF WBC count | 11,692.3 (32,494.4) | 2674.8 (5440.94) | .3 |
| CSF glucose | 29 (14.3) | 18.1 (11) | .04 |
| CSF protein | 309.8 (236.9) | 505.5 (216.1) | .04 |